Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate receptor ionotropic, NMDA 2A (GluN2A) is a subunit of the NMDA receptor, a glutamate-gated ion channel crucial for excitatory neurotransmission, synaptic plasticity, learning, memory, and brain development. NMDA receptors are heterotetrameric complexes, typically with two GluN1 and two GluN2 subunits. GluN2A-containing receptors contribute to long-term potentiation and synaptic plasticity. Mutations in GRIN2A, the gene encoding GluN2A, can cause epilepsy and other neurological disorders due to altered NMDA receptor function and neuronal excitability.
NMDA receptor modulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate receptor ionotropic, NMDA 2A (GluN2A).